tiprankstipranks
Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
US Market

Compare Acumen Pharmaceuticals (ABOS) vs. Competitors

726 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Acumen Pharmaceuticals
$2.70
$194.97M
-1.27
150.00%
3 Buy
0 Hold
0 Sell
Strong Buy
VistaGen Therapeutics
$0.59
$23.24M
-0.37
-75.48%
0 Buy
2 Hold
0 Sell
Hold
Inhibikase Therapeutics
$1.80
$237.66M
-4.18
-17.43%
5 Buy
0 Hold
0 Sell
Strong Buy
Surrozen
$27.87
$320.13M
-0.70
134.99%
4 Buy
0 Hold
0 Sell
Strong Buy
TScan Therapeutics
$1.01
$57.47M
-1.41
-20.47%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ABOS
Acumen Pharmaceuticals
2.70
1.65
157.14%
VTGN
VistaGen Therapeutics
0.59
-1.58
-73.00%
ADVM
IKT
Inhibikase Therapeutics
1.80
0.12
7.14%
SRZN
Surrozen
27.87
18.07
184.39%
TCRX
TScan Therapeutics
1.01
-0.25
-19.84%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts